Bnp Paribas Asset Management Holding S.A. Genmab A/S Transaction History

Bnp Paribas Asset Management Holding S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$37.4 - $42.94 $29,284 - $33,622	-783 Reduced 3.2%	23,704 $901,000
Q1 2023 May 08, 2023	BUY	$34.88 - $43.22 $101,361 - $125,597	2,906 Added 13.47%	24,487 $925,000
Q4 2022 Feb 09, 2023	SELL	$33.8 - $47.06 $257,792 - $358,926	-7,627 Reduced 26.11%	21,581 $915,000
Q3 2022 Nov 10, 2022	SELL	$31.52 - $373.61 $133,392 - $1.58 Million	-4,232 Reduced 12.66%	29,208 $938,000
Q2 2022 Aug 04, 2022	BUY	$26.83 - $38.57 $3,648 - $5,245	136 Added 0.41%	33,440 $1.09 Million
Q1 2022 May 12, 2022	SELL	$30.95 - $39.68 $414,049 - $530,839	-13,378 Reduced 28.66%	33,304 $1.21 Million
Q4 2021 Feb 09, 2022	BUY	$35.87 - $47.12 $263,178 - $345,719	7,337 Added 18.65%	46,682 $1.85 Million
Q3 2021 Nov 08, 2021	SELL	$41.55 - $48.72 $2.94 Million - $3.44 Million	-70,638 Reduced 64.23%	39,345 $1.72 Million
Q2 2021 Aug 05, 2021	SELL	$32.88 - $44.57 $5,326 - $7,220	-162 Reduced 0.15%	109,983 $4.49 Million
Q1 2021 May 05, 2021	BUY	$30.92 - $44.4 $590,046 - $847,285	19,083 Added 20.96%	110,145 $3.62 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $3.07 Million - $3.71 Million	91,062 New	91,062 $3.7 Million

240

52.6M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.